WASHINGTON, DC –House Energy and Commerce Committee leaders sent a letter to the International Academy of Compounding Pharmacists seeking information on the role of this industry association in assisting compounding pharmacies in their interactions with federal and state authorities. A bipartisan group of committee leaders wrote, “Allegations that your association may have enc
Chairman:
Cliff Stearns (FL-06)
Jurisdiction:
Responsibility for oversight of agencies, departments, and programs related to the jurisdiction of the full committee, and for conducting investigations.
Members
Republicans
Cliff Stearns (FL), Chair
Lee Terry (NE)
-Vice Chair, C&T
John Sullivan (OK)
-Vice Chair, E&P
Tim Murphy (PA)
-Vice Chair, E&E
Michael Burgess (TX)
-Vice Chair, Health
Marsha Blackburn (TN)
-Vice Chair, CMT
Sue Myrick (NC)
-Vice Chair, Full Committee
Brian Bilbray (CA)
Phil Gingrey (GA)
Steve Scalise (LA)
Cory Gardner (CO)
Morgan Griffith (VA)
Joe Barton (TX)
Fred Upton (MI)
Democrats
Diana DeGette (CO), Ranking Member
Jan Schakowsky (IL)
Mike Ross (AK)
Kathy Castor (FL)
Edward J. Markey (MA)
Gene Green (TX)
Donna Christensen (VI)
John D. Dingell (MI)
Henry A. Waxman (CA)
December 7, 2012 |
Press Release
December 7, 2012 |
Letter
Excerpt: Allegations that your association may have encouraged compounding pharmacists to attempt to impede FDA from evaluating the efficacy and safety of their products, if true, raise serious concerns about your actions.
To read the letter, click here.
November 28, 2012 |
Press Release
WASHINGTON, DC – After once again being selected by his colleagues to serve as Chairman of the U.S. House Committee on Energy and Commerce, Congressman Fred Upton (R-MI) today announced the committee leadership he intends to appoint for the 113th Congress and commented on key priorities for the future. Rep. Lee Terry (R-NE) will succeed Rep.
November 19, 2012 |
Press Release
WASHINGTON, DC – House Energy and Commerce Republican leaders late last week requested the Food and Drug Administration provide internal documents related to the deadly meningitis outbreak by November 30, 2012.
November 19, 2012 |
Letter
Excerpt: In order to effectively and responsibly address the question of clarifying or enhancing FDA’s authority over compounding pharmacies, the committee must identify what happened at the New England Compounding Center (NECC), and why FDA did not use its authority to take enforcement action against NECC until October 2012, after the meningitis outbreak.
November 15, 2012 |
Letter
Excerpt: We write to express our strong opposition to certain provisions relating to the Department of Energy’s nuclear defense and related programs in the House-passed national defense authorization bill.